Riskpilot← Back to searchSign inGet full accessAXICORP ApS
APSIn liquidationCVR 34622620Skolevængets Alle 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2012— employees
Revenue 2024
DKK -37K
+13% vs 2023
EBITDA margin
100.0%
-13% vs 2023
Equity ratio
66.0%
Financial strength
Net profit 2024
DKK -27K
-16% vs 2023
| Revenue | DKK -37K | +13% |
| EBITDA | DKK -37K | -13% |
| Net profit | DKK -27K | -16% |
| Total assets | DKK 300K | +2% |
| Equity | DKK 198K | -12% |
| Employees | — | — |
Legal name
AXICORP ApS
CVR number
34622620
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
31. juli 2012
Share capital
DKK 80.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er fremstilling, salg og distribution af lægemidler, samt hermed beslægtet virksomhed
Address
Skolevængets Alle 2
Email
katharina.reineck@axicorp.de
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -538 | -227 | -23 | 34 | -32 | -30 | -28 | -30 | -28 | -18 | -33 | -37 |
| Staff expenses | -499 | -121 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1.036 | -348 | -23 | 34 | -32 | -30 | -28 | -30 | -28 | -18 | -33 | -37 |
| Depreciation & amort. | -55 | -11 | -7 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1.091 | -359 | -30 | 34 | -32 | -30 | -28 | -30 | -28 | -18 | -33 | -37 |
| Net financials | -2 | -0 | 0 | -6 | 0 | 0 | 0 | -0 | 0 | 0 | 9 | 9 |
| Profit before tax | -1.094 | -359 | -30 | 28 | -32 | -30 | -28 | -31 | -28 | -18 | -24 | -27 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.094 | -359 | -30 | 28 | -32 | -30 | -28 | -31 | -28 | -18 | -24 | -27 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.720 | 124 | 1.461 | 63 | 444 | 373 | 362 | 349 | 346 | 292 | 293 | 300 |
| Equity | -1.083 | -1.442 | 28 | 56 | 383 | 353 | 325 | 294 | 267 | 249 | 225 | 198 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.739 | 1.488 | 1.433 | 7 | 60 | 21 | 37 | 55 | 80 | 44 | 68 | 102 |
| Total debt | 2.739 | 1.488 | 1.433 | 7 | 60 | 21 | 37 | 55 | 80 | 44 | 68 | 102 |
EBITDA margin
-3668400.0%
This company
15.8%
Market median
-23217822% vs market
20132024
Equity ratio
66.0%
This company
38.2%
Market median
+73% vs market
20132024
Return on equity
-13.8%
This company
18.4%
Market median
-175% vs market
20132024
Net profit margin
-2738500.0%
This company
8.1%
Market median
-33808742% vs market
20132024
Asset turnover
-0.12×
This company
1.12×
Market median
-111% vs market
20132024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-07-31 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HF Management | Management | 2023 | — | — |
DU Management | Management | 2012 | — | — |
GB Unofficial title | Unofficial title | 2026 | — | — |
AG Management | Management | 2017 | — | — |
UF Founder | Founder | 2012 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AXICORP ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans-Georg Feldmeier | Management | 0 companies |
| Dirk Ullrich | Management | 0 companies |
| Gülsah Bektas | Unofficial title | 0 companies |
| Anna-Karina Gerner | Management | 0 companies |
| Ulrik Fleischer-Michaelsen | Founder | 0 companies |